Atlas Certification to Enable Development of MDx-related Software | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Atlas Biolabs today said that it has achieved DIN EN ISO 13485:2003 + AC:2009 standard, allowing the company to develop a software-based expert system for assessing chromosomal aberrations.

The system will complement Atlas' genotyping and molecular karyotyping services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.